RwHealth the AI provider for the NHS reports 160% growth

The past year has seen vast digital transformation, and AI has been implemented in healthcare to benefit organisations in many ways

RwHealth, the leading provider of artificial intelligence (AI) to the healthcare industry, has reported 160% year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers, and pharmaceutical companies.

Founded in 2017, RwHealth is headquartered in London's Canary Wharf. It works with more than 70 UK and international providers, and its AI technology has processed more than 10 million UK patients and 5.5 million across the Middle East and Australia. 

How does the company use AI? 


The company’s Data Science Platform combines AI and machine learning to give healthcare providers in-depth data to make better decisions and improve patient outcomes. 

Being able to model patient numbers has been vital during Covid, and the RwHealth platform has helped UK hospitals to anticipate demand, combat bed shortages, and tackle worsening waiting list issues.

RwHealth's success mirrors the wider growth of AI in healthcare, as stakeholders across the health ecosystem find new ways to increase efficiency, save money, and deliver optimised clinical outcomes. In September 2020, NHSX, the organisation driving digital transformation in health and social care, announced a £250m investment into AI in UK healthcare.

Orlando Agrippa, CEO, and Founder of RwHealth, said: "We've grown at an extraordinary rate, as healthcare providers realise how AI can improve patient outcomes while helping to ease the wider pressures that the healthcare industry faces. It's important to tackle backlogs and bed capacity issues so that healthcare remains safe and steady as we attempt to recover post-Covid."

The acceleration of AI in healthcare


The rise of data in healthcare means that artificial intelligence (AI) has the potential to help transform the industry.  

AI is now one of the top priorities for healthcare decision-makers, governments, investors, and innovators. An increasing number of governments have set out aspirations for AI in healthcare, such as Finland, Germany, the United Kingdom, Israel, China, and the United States. The private sector continues to play a significant role, with venture capital (VC) funding for the top 50 firms in healthcare-related AI reaching $8.5 billion, and big tech firms, startups, pharmaceutical and medical-devices firms and health insurers, all engaging with the nascent AI healthcare ecosystem.

The UK has the second-highest number of AI-driven healthcare technologies in development globally after the US, according to NIHR Innovation Observatory’s Mapping the Global Activity of AI Health Technologies, 2021.



Featured Articles

New chips for artificial intelligence could be game changer

Energy-efficient and faster than its silicon-based counterparts, researchers have developed a new computer chip optimised for artificial intelligence

Securing the future of IoT with AI biometric technology

The world needs an IoT future, so It’s time to forget your password – for good. A new breed of AI-powered biometric security measures is required

EU networks plan to build a foundation for trustworthy AI

Artificial intelligence technologies are in their infancy, but commercial stakeholders must build them on foundations of trust, say research experts

ICYMI: Power users distrust AI and new National Robotarium


Reducing the impact of ecommerce with AI and ML

AI Applications

Now is the time for intelligent products and services

AI Strategy